Nurix Therapeutics, Inc. financial data

Symbol
NRIX on Nasdaq
Location
Brisbane, CA
Fiscal year end
30 November
Latest financial report
10-Q - Q3 2025 - 09 Oct 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 622% % 46%
Debt-to-equity 31% % -39%
Return On Equity -54% % 15%
Return On Assets -41% % 2.4%
Operating Margin -195% % 56%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 76,883,436 shares 8.5%
Common Stock, Shares, Outstanding 76,872,686 shares 15%
Entity Public Float $995,900,000 USD 112%
Common Stock, Value, Issued $77,000 USD 15%
Weighted Average Number of Shares Outstanding, Basic 84,159,336 shares 16%
Weighted Average Number of Shares Outstanding, Diluted 84,159,336 shares 16%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $80,887,000 USD 94%
Revenue from Contract with Customer, Excluding Assessed Tax $83,687,000 USD -37%
Research and Development Expense $301,103,000 USD 48%
General and Administrative Expense $49,812,000 USD 8.3%
Operating Income (Loss) $267,228,000 USD -38%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $244,017,000 USD -38%
Income Tax Expense (Benefit) $768,000 USD 193%
Net Income (Loss) Attributable to Parent $244,785,000 USD -38%
Earnings Per Share, Basic -2 USD/shares -1.7%
Earnings Per Share, Diluted -2 USD/shares -1.7%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $78,438,000 USD -21%
Cash, Cash Equivalents, and Short-term Investments $428,800,000 USD -4.3%
Accounts Receivable, after Allowance for Credit Loss, Current $19,000,000 USD
Assets, Current $440,603,000 USD -3.4%
Property, Plant and Equipment, Net $20,498,000 USD 20%
Operating Lease, Right-of-Use Asset $53,028,000 USD 96%
Other Assets, Noncurrent $7,375,000 USD 143%
Assets $522,472,000 USD 1.7%
Accounts Payable, Current $8,609,000 USD 120%
Employee-related Liabilities, Current $16,370,000 USD 40%
Contract with Customer, Liability, Current $25,993,000 USD -46%
Liabilities, Current $82,350,000 USD -4.6%
Contract with Customer, Liability, Noncurrent $15,175,000 USD -49%
Operating Lease, Liability, Noncurrent $52,695,000 USD 156%
Liabilities $150,220,000 USD 9.9%
Accumulated Other Comprehensive Income (Loss), Net of Tax $119,000 USD -65%
Retained Earnings (Accumulated Deficit) $925,005,000 USD -36%
Stockholders' Equity Attributable to Parent $372,252,000 USD -1.2%
Liabilities and Equity $522,472,000 USD 1.7%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $61,087,000 USD -46%
Net Cash Provided by (Used in) Financing Activities $1,473,000 USD -9.3%
Net Cash Provided by (Used in) Investing Activities $25,533,000 USD -28%
Common Stock, Shares Authorized 500,000,000 shares 0%
Common Stock, Shares, Issued 76,872,686 shares 15%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $34,081,000 USD -608%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $79,406,000 USD -21%
Deferred Tax Assets, Valuation Allowance $227,050,000 USD 17%
Deferred Tax Assets, Gross $233,139,000 USD 15%
Operating Lease, Liability $28,303,000 USD -7.5%
Payments to Acquire Property, Plant, and Equipment $3,485,000 USD 21%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $245,010,000 USD -40%
Lessee, Operating Lease, Liability, to be Paid $38,450,000 USD -9.4%
Property, Plant and Equipment, Gross $61,230,000 USD 25%
Operating Lease, Liability, Current $3,791,000 USD -42%
Lessee, Operating Lease, Liability, to be Paid, Year Two $2,912,000 USD -36%
Lessee, Operating Lease, Liability, to be Paid, Year One $8,240,000 USD 7.8%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $10,147,000 USD -14%
Lessee, Operating Lease, Liability, to be Paid, Year Three $2,992,000 USD 2.7%
Deferred Tax Assets, Operating Loss Carryforwards $91,786,000 USD -0.37%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10,000,000 shares 0%
Unrecognized Tax Benefits $21,866,000 USD 41%
Lessee, Operating Lease, Liability, to be Paid, Year Four $3,074,000 USD 2.7%
Operating Lease, Payments $2,151,000 USD 12%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance $6,089,000 USD -32%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%